PET/CT in Hodgkin’s Lymphoma

PET/CT in Hodgkin’s Lymphoma
Author: Irfan Kayani
Publisher: Springer
Total Pages: 100
Release: 2017-07-28
Genre: Medical
ISBN: 3319572253

This book is a pocket guide to the practice of PET/CT imaging of Hodgkin’s lymphoma. The role of PET/CT in Hodgkin’s lymphoma, the characteristic findings and patterns, and the advantages and limitations of this hybrid modality are all clearly described. In addition, information is provided on clinical presentation, diagnosis, staging, pathology, management, and conventional radiological imaging. A useful pictorial atlas is included at the end of the book. PET/CT in Hodgkin’s Lymphoma is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging, which is aimed at referring clinicians, nuclear medicine/radiology physicians, radiographers/technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings. Compiled under the auspices of the British Nuclear Medicine Society, the series is the joint work of many colleagues and professionals worldwide who share a common vision and purpose in promoting and supporting nuclear medicine as an important imaging specialty for the diagnosis and management of oncological and non-oncological conditions.

PET/CT in Non-Hodgkin Lymphoma

PET/CT in Non-Hodgkin Lymphoma
Author: Archi Agrawal
Publisher: Springer Nature
Total Pages: 115
Release: 2021-08-17
Genre: Medical
ISBN: 303079007X

This book provides an up-to-date summary of the latest scientific developments on the use of PET-CT imaging in Non-Hodgkin Lymphoma (NHL). It encompasses the entire spectrum of NHL – from pathology to radiological and PET-CT imaging and to the management of NHL. The highlight of the book is the excellent pictorial depiction of normal variants, pitfalls and artifacts while exploring the different types of NHL and its manifestations. Each chapter, written by well-known and experienced oncologists and physicians, is enriched by a wide range of images to ensure a clear concept of PET-CT imaging in NHL and will definitely keep the readers interested. This book will be a useful tool for nuclear physicians, radiologists, referring clinicians and oncologists, as well as para-medical staff working in this field.

PET Scan in Hodgkin Lymphoma

PET Scan in Hodgkin Lymphoma
Author: Andrea Gallamini
Publisher: Springer
Total Pages: 143
Release: 2016-07-04
Genre: Medical
ISBN: 3319317970

This book describes the various contributions of positron emission tomography (PET) to the management of Hodgkin lymphoma and considers key issues in its use. A full explanation of the value of PET in disease staging and restaging is followed by discussion of its role in guiding individualized, response-adapted therapy in both early and advanced disease based on assessment of treatment sensitivity. Further chapters explore in detail the current application of PET for determination of tumor metabolic volume and planning of involved field radiotherapy. The book concludes by discussing PET scan reporting in clinical practice and the rules that have now been formally set following a number of international workshops designed to develop standard reporting criteria based on expert agreement. The authors are leading authorities who adopt an interdisciplinary approach in covering the most important aspects of the use of PET in Hodgkin lymphoma in a readily understandable way. PET Scan in Hodgkin Lymphoma will be of value to oncologists, hematologists, medical physicists, radiotherapists, and nuclear medicine specialists.

PET/CT in Lymphomas

PET/CT in Lymphomas
Author: John A. Andreou
Publisher: Springer
Total Pages: 371
Release: 2016-04-19
Genre: Medical
ISBN: 3319273809

Drawing on an extensive series of cases, this book describes and illustrates in detail the FDG-PET/CT appearances of the most common lymphomas in both adults and children, covering presentations at various anatomic sites. In addition, all other aspects of the current application of FDG-PET/CT in the evaluation and management of patients with malignant lymphomas are described. Full explanations are provided of the potential benefits and limitations of advanced PET/CT techniques and technologies that support novel chemotherapy and radiotherapy approaches in the treatment of lymphoma, and particular attention is paid to the major challenge of incorporating progress in quantitative imaging technology into radiotherapy treatment planning, guidance, and monitoring. This clinical case-based atlas will be an invaluable tool for radiologists, hematologists, and clinical oncologists.

Clinical PET and PET/CT

Clinical PET and PET/CT
Author: H. Jadvar
Publisher: Springer Science & Business Media
Total Pages: 277
Release: 2006-01-20
Genre: Medical
ISBN: 1846281008

A practical manual covering the full spectrum of PET and PET/CT imaging, now in common clinical practice, this book includes images of normal variants, artifacts, and pathologic conditions. Indications for and the relative clinical value of PET in the armamentarium of diagnostic medical imaging are reviewed. The information in the book is organized to be brief, concise, easy-to-understand and readily accessed. This book is intended for all health practitioners who need a concise reference and review of PET imaging indications, protocols and clinical applications. It will be useful to radiologists, nuclear medicine physicians, and clinicians who refer their patients to PET Centers for diagnostic imaging, including neurologists, neurosurgeons, psychiatrists, cardiologists, internists, and oncologists. Radiologic and nuclear medicine technologists, and physicians in training will also benefit from this work.

PET Imaging of Lymphoma, An Issue of PET Clinics

PET Imaging of Lymphoma, An Issue of PET Clinics
Author: Rebecca Elstrom
Publisher: Elsevier Health Sciences
Total Pages: 153
Release: 2012-01-28
Genre: Medical
ISBN: 1455743054

This issue provides a complete update on PET imaging of lymphoma, starting with a clinical assessment of lymphoma and the role of medical imaging. The role of structural imaging in lymphoma is then discussed. From a Nuclear Medicine perspective, FDG-PET in lymphoma is reviewed, as is the role of FDG-PET in pediatric lymphoma. Next, the role of non-FDG tracers in lymphoma is reviewed. Other articles cover the role of fMRI and optical imaging in lymphoma, the role of diffusion-weighted MRI in lymphoma, FDG-PET in personalization of therapy in patients with lymphoma, and PET and radiation oncology in lymphoma.

The Heterogeneity of Cancer Metabolism

The Heterogeneity of Cancer Metabolism
Author: Anne Le
Publisher: Springer
Total Pages: 186
Release: 2018-06-26
Genre: Medical
ISBN: 331977736X

Genetic alterations in cancer, in addition to being the fundamental drivers of tumorigenesis, can give rise to a variety of metabolic adaptations that allow cancer cells to survive and proliferate in diverse tumor microenvironments. This metabolic flexibility is different from normal cellular metabolic processes and leads to heterogeneity in cancer metabolism within the same cancer type or even within the same tumor. In this book, we delve into the complexity and diversity of cancer metabolism, and highlight how understanding the heterogeneity of cancer metabolism is fundamental to the development of effective metabolism-based therapeutic strategies. Deciphering how cancer cells utilize various nutrient resources will enable clinicians and researchers to pair specific chemotherapeutic agents with patients who are most likely to respond with positive outcomes, allowing for more cost-effective and personalized cancer therapeutic strategies.

Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology

Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology
Author: Stefano Fanti
Publisher: Springer Nature
Total Pages: 488
Release: 2021-07-07
Genre: Medical
ISBN: 3030688585

This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.

Comparative Analysis of Treatment Response in Hodgkin and Non-Hodgkin Lymphoma Patients Using FDG PET/CT Scans

Comparative Analysis of Treatment Response in Hodgkin and Non-Hodgkin Lymphoma Patients Using FDG PET/CT Scans
Author: Malik Ibrawish
Publisher: GRIN Verlag
Total Pages: 62
Release: 2023-07-13
Genre: Medical
ISBN: 3346906426

Bachelor Thesis from the year 2023 in the subject Medicine - Radiology, Nuclear Medicine, grade: 90, , language: English, abstract: This study seeks to compare the treatment responses of Hodgkin and non-Hodgkin lymphoma patients using FDG PET/CT scans. 152 patients with histologically confirmed Hodgkin and non-Hodgkin lymphomas, who had undergone FDG PET/CT imaging for evaluating their treatment response after their initial chemotherapy regimen, were included in a retrospective study. The findings revealed that Hodgkin's lymphoma was more prevalent in females, and both types of lymphomas showed similar complete metabolic responses. However, Hodgkin's lymphoma demonstrated higher mild/high partial responses, and non-Hodgkin's lymphoma showed lower progressive metabolic disease.